Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2)
Conditions: HIV; HIV/AIDS; HIV-1 Infection Interventions: Drug: Pegylated Interferon alpha 2b (peg-IFN-α2b); Drug: 3BNC117 + 10-1074 Sponsors: Luis Montaner; University of Pennsylvania; Philadelphia Fight; Rockefeller University; Merck Sharp & Dohme Corp.; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials